Topic: Market sharing

A basketball union has filed a complaint with the European Commission accusing the organisers of a pan-European league and 11 of the continent’s best-known teams of conspiring to block others from competing.

02 October 2020

The UK’s electricity grid operator has settled for an undisclosed sum its damages claim against NKT following-on from the European Commission’s power cables cartel decision.

17 September 2020

The Competition Tribunal of South Africa has thrown out a cartel case against a frozen foods company because the country’s antitrust enforcer could not prove that its contract with a beef producer qualified as a market allocation agreement or had any impact on competition.

16 September 2020

A federal judge in Illinois has allowed a group of dentists to progress their claims against Delta Dental insurers for conspiring to restrain competition.

10 September 2020

Assistant attorney general Makan Delrahim has warned the head of the world’s soccer governing body that it could violate antitrust laws by restricting the territory in which teams can play league games, according to a letter released this week.

04 September 2020

The former president of an heir location service has asked an Illinois federal court to reject the Department of Justice’s recommendation of a 13-month incarceration sentence for his role in a nine-year cartel.

28 August 2020

Poland’s antitrust authority has fined two cattle feed producers €3.8 million for sharing the market by agreeing not to supply each other’s customers.

26 August 2020

Chile’s highest court has imposed fines totalling US$19.6 million on Eukor, CMC and K-Line, after overturning a decision by the country’s competition tribunal not to impose sanctions on the companies for their role in the global roll-on roll-off shipping cartel.

17 August 2020

Attending a meeting where price-fixing or market allocation agreements are made does not automatically prove a company is guilty of participating in a cartel, an appellate court in South Africa has ruled.

14 August 2020

Taro Pharmaceuticals has entered into a deferred prosecution agreement with the Antitrust Division, but it is costing the generic drugmaker $419 million and an admission that its price-fixing conspiracy impacted more than $500 million worth of commerce.

24 July 2020